At-home Breast Oncology Care Delivered With E-health Solutions
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity Health Network, Toronto
About this trial
The COVID-19 pandemic has significantly impacted healthcare service delivery, highlighting the need for high quality virtual patient care. Our team has developed a multi-dimensional remote eHealth solution for newly diagnosed breast cancer patients and their practitioners to use during the diagnostic and follow-up period. The ABODE study involved development of a Breast Cancer Treatment Application (app) which will facilitate virtual consultations, deliver patient education material, and collect patient reported outcome measures (PROMs). Using a randomized controlled trial design, the team will evaluate a variety of outcomes for breast cancer patients who will use the app throughout their diagnosis and treatment period.
Primary Objective: To compare changes in patient activation (assessed by PAM-13) over 1 year among newly diagnosed breast cancer patients between those using the app and those receiving standard care.
Secondary Objectives:
1. Compare additional PROMs between the standard care and intervention groups 2. Describe health service outcomes among app users 3. Explore end-user experience of using the app 4. Measure activity levels using wearable devices
Eligibility criteria
Qualifiers
Females (assigned female at birth)*
Diagnosed with first, primary invasive BC
Must have surgery as their first step in treatment pathway
Age≥18
Disqualifiers
Males (assigned male at birth), as BC surgical treatment options and experiences are different
Diagnosed with non-operable breast cancer
Stage 4/metastatic (whether determined at diagnosis or during surgery)
Those with hearing or visual challenges
Trial design
Treatments tested in this trial
- At-home Breast Oncology care Delivered with E-health solutions - ABODE
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov